Tag: clinical trials

Regulatory Views on Statistical Data Surveillance in RBM Programs

Posted on By digi

Regulatory Views on Statistical Data Surveillance in RBM Programs Regulatory Views on Statistical Data Surveillance in RBM Programs Introduction to Statistical Data Surveillance in Risk-Based Monitoring In the evolving landscape of clinical trials, especially in the context of at home clinical trials, organizations must focus on risk-based monitoring (RBM) as a critical strategy to enhance…

Read More “Regulatory Views on Statistical Data Surveillance in RBM Programs” »

Statistical Data Surveillance

Handling Non-Standard Data: Devices, Digital Biomarkers and RWD

Posted on By digi

Handling Non-Standard Data: Devices, Digital Biomarkers and RWD Handling Non-Standard Data: Devices, Digital Biomarkers and RWD Clinical trials play a vital role in advancing medical knowledge and improving patient outcomes. However, the landscape of data management is continuously evolving, particularly with the integration of non-standard data sources such as devices, digital biomarkers, and real-world data…

Read More “Handling Non-Standard Data: Devices, Digital Biomarkers and RWD” »

Data Standards (CDISC: SDTM, ADaM)

Regulatory Expectations for CDISC Conformance in US, EU and Japan

Posted on By digi

Regulatory Expectations for CDISC Conformance in US, EU and Japan As clinical research continues to evolve, the need for standardized data reporting and submission processes becomes imperative. Central to this effort is the Clinical Data Interchange Standards Consortium (CDISC), which provides pivotal guidelines for clinical data management and submission. This article serves as a comprehensive…

Read More “Regulatory Expectations for CDISC Conformance in US, EU and Japan” »

Data Standards (CDISC: SDTM, ADaM)

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks

Posted on By digi

Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks In the realm of clinical trials, particularly adaptive platform trials, interim analyses serve as critical checkpoints that can influence the overall study trajectory. This tutorial aims to provide an in-depth understanding of the operational and regulatory risks…

Read More “Blinded vs Unblinded Interim Analyses: Operational and Regulatory Risks” »

Interim Analyses & Alpha Spending

Data Visualization for Statistical Surveillance: Plots That Reveal Risk

Posted on By digi

Data Visualization for Statistical Surveillance: Plots That Reveal Risk Data visualization is an intricate yet essential component in the realm of statistical surveillance for clinical trials. With the increasing complexity of clinical research, particularly in the context of rfp clinical trials, the effective presentation of data through plots can unfold insights that may not be…

Read More “Data Visualization for Statistical Surveillance: Plots That Reveal Risk” »

Statistical Data Surveillance

Handling False Positives and Noise in Surveillance Signals

Posted on By digi

Handling False Positives and Noise in Surveillance Signals Handling False Positives and Noise in Surveillance Signals In the realm of clinical research, particularly within the domains of statistical data surveillance and risk-based monitoring (RBM), the issue of false positives and noise in surveillance signals is a significant concern. This article serves as a comprehensive tutorial…

Read More “Handling False Positives and Noise in Surveillance Signals” »

Statistical Data Surveillance

Coordinating Standards Across CROs, Vendors and Internal Teams

Posted on By digi

Coordinating Standards Across CROs, Vendors and Internal Teams In the complex landscape of clinical trials, the integration of standards across Contract Research Organizations (CROs), vendors, and internal teams is essential for achieving quality and compliance. This guide offers a step-by-step approach to establish and maintain data standards effectively, particularly under the frameworks established by CDISC:…

Read More “Coordinating Standards Across CROs, Vendors and Internal Teams” »

Data Standards (CDISC: SDTM, ADaM)

Using Standards to Accelerate Submission, Review and Data Reuse

Posted on By digi

Using Standards to Accelerate Submission, Review and Data Reuse Using Standards to Accelerate Submission, Review and Data Reuse In the evolving landscape of clinical research, organizations are increasingly adopting standards that optimize data management processes. The integration of data standards such as CDISC’s SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) supports clinical…

Read More “Using Standards to Accelerate Submission, Review and Data Reuse” »

Data Standards (CDISC: SDTM, ADaM)

Setting Up Independent Data Monitoring Committees (DMC/IDMC)

Posted on By digi

Setting Up Independent Data Monitoring Committees (DMC/IDMC) The establishment and operation of Independent Data Monitoring Committees (DMC) or Independent Data Monitoring Committees (IDMC) is crucial in clinical trials for ensuring participant safety and the integrity of data. This guide provides a step-by-step approach to setting up a DMC, focusing on compliance with regulatory requirements in…

Read More “Setting Up Independent Data Monitoring Committees (DMC/IDMC)” »

Interim Analyses & Alpha Spending

Designing Surveillance Plans Tailored to Study Size and Complexity

Posted on By digi

Designing Surveillance Plans Tailored to Study Size and Complexity Designing Surveillance Plans Tailored to Study Size and Complexity In the rapidly evolving landscape of clinical research, the importance of creating robust surveillance plans cannot be overstated. Surveillance plans help ensure that clinical trials are conducted in compliance with regulatory standards while optimizing patient safety and…

Read More “Designing Surveillance Plans Tailored to Study Size and Complexity” »

Statistical Data Surveillance